Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2002-2-18
pubmed:abstractText
Intrinsic chemoresistance constitutes a major problem in the therapy of malignant gliomas. In vitro experiments with four astrocytoma/glioblastoma (AC/GBM) cell lines revealed that the chemoresistance of two cell lines, A172 and T98G, to cisplatin and etoposide was due to resistance to drug-induced apoptosis. In contrast, all the AC/GBM cell lines tested were sensitive to treatment with the lipophilic ether lipid erucylphosphocholine, ErPC. ErPC-induced apoptosis was independent of wild-type p53-signaling and triggering of the CD95/CD95 ligand (CD95L) system. Inhibition of protein and RNA synthesis by cycloheximide and actinomycin D did not abrogate ErPC-induced apoptosis. However, expression of members of the bcl-2 protein family was modulated during ErPC treatment. Activation of caspase 3 and mitochondrial alterations were central to ErPC-induced apoptosis. We conclude that ErPC-induced activation of the mitochondrial pathway enables cell death in the chemoresistant AC/GBM cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/BCL2L1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Bcl2l1 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/CASP3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Casp3 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3, http://linkedlifedata.com/resource/pubmed/chemical/Caspases, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/FASLG protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Phosphorylcholine, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Tnfsf6 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/bcl-X Protein, http://linkedlifedata.com/resource/pubmed/chemical/erucylphosphocholine
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3389-96
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11848499-Animals, pubmed-meshheading:11848499-Antigens, CD95, pubmed-meshheading:11848499-Antineoplastic Agents, pubmed-meshheading:11848499-Apoptosis, pubmed-meshheading:11848499-Astrocytoma, pubmed-meshheading:11848499-Caspase 3, pubmed-meshheading:11848499-Caspases, pubmed-meshheading:11848499-Cisplatin, pubmed-meshheading:11848499-Down-Regulation, pubmed-meshheading:11848499-Drug Resistance, Multiple, pubmed-meshheading:11848499-Drug Resistance, Neoplasm, pubmed-meshheading:11848499-Enzyme Activation, pubmed-meshheading:11848499-Etoposide, pubmed-meshheading:11848499-Fas Ligand Protein, pubmed-meshheading:11848499-Glioblastoma, pubmed-meshheading:11848499-Humans, pubmed-meshheading:11848499-Intracellular Membranes, pubmed-meshheading:11848499-Membrane Glycoproteins, pubmed-meshheading:11848499-Membrane Potentials, pubmed-meshheading:11848499-Mitochondria, pubmed-meshheading:11848499-Phosphorylcholine, pubmed-meshheading:11848499-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:11848499-Rats, pubmed-meshheading:11848499-Signal Transduction, pubmed-meshheading:11848499-Tumor Cells, Cultured, pubmed-meshheading:11848499-bcl-X Protein
pubmed:articleTitle
Erucylphosphocholine-induced apoptosis in chemoresistant glioblastoma cell lines: involvement of caspase activation and mitochondrial alterations.
pubmed:affiliation
Department of Physiology, University of Tübingen, Medical School, Germany. verena.jendrossek@uni-tuebingen.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't